Guidelines for COVID-19 management in hematopoietic cell transplantation and cellular therapy recipients Guidelines
| Authors: | Waghmare, A.; Abidi, M. Z.; Boeckh, M.; Chemaly, R. F.; Dadwal, S.; El Boghdadly, Z.; Kamboj, M.; Papanicolaou, G. A.; Pergam, S. A.; Shahid, Z. |
| Title: | Guidelines for COVID-19 management in hematopoietic cell transplantation and cellular therapy recipients |
| Abstract: | There are currently limited data on the epidemiology, clinical manifestations, and optimal management of Coronavirus Disease 2019 (COVID-19) in hematopoietic cell transplantation and cellular therapy recipients. Given the experience with other respiratory viruses, we anticipate that patients may develop severe clinical disease and thus provide the following general principles for cancer centers across the nation. These guidelines were developed by members of the American Society for Transplantation and Cellular Therapy Infectious Diseases Special Interest Group. Specific practices may vary depending on local epidemiology and testing capacity, and the guidance provided in this document may change as new information becomes available. © 2020 American Society for Transplantation and Cellular Therapy |
| Keywords: | practice guideline; cellular therapy; covid-19; sars-cov-2; hematopoietic cell transplan |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 26 |
| Issue: | 11 |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-11-01 |
| Start Page: | 1983 |
| End Page: | 1994 |
| Language: | English |
| DOI: | 10.1016/j.bbmt.2020.07.027 |
| PUBMED: | 32736007 |
| PROVIDER: | scopus |
| PMCID: | PMC7386267 |
| DOI/URL: | |
| Notes: | MSK author Miguel Angel Perales was thanked in the acknowledgements for their input -- Article -- Export Date: 1 December 2020 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
238Papanicolaou -
158Kamboj
Related MSK Work